Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD charlotteobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from charlotteobserver.com Daily Mail and Mail on Sunday newspapers.
15.02.2023 - Psycheceutical enters into agreement with iNGENū to conduct human clinical trials of NeuroDirect ketamine topical in AustraliaPhase I trial will study 20 people to test the safety, tolerability, and pharmacokinetics of a single dose of . Seite 1